David T. Hung's Insider Trades & SAST Disclosures
David T. Hung's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 300,000 Class A Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on April 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David T. Hung.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 04 Apr 2025 | 300,000 | 58,781,054 | - | 1.6 | 487,500 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 04 Apr 2025 | 200,000 | 58,481,054 | - | 1.7 | 332,720 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,000,000 | 2,000,000 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,053 | 13,194 | - | 0 | Restricted Stock Units | |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 2,000,000 | 2,000,000 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,554 | 12,554 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,350 | 4,350 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 2,427 | 9,141 | - | 0 | Restricted Stock Units | |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 2,000,000 | 2,000,000 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,499 | 1,499 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 814 | 6,714 | - | 0 | Restricted Stock Units | |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 2,500,000 | 2,500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | David T. Hung | Director, President and CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Mar 2021 | 368,408 | 58,281,054 | - | 0 | Class A Common Stock | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 5,101 | 5,101 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 2,541 | 5,900 | - | 0 | Restricted Stock Units | |
| Establishment Labs Holding... | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges